Pharmacological profile of 4-(2',4'-difluorobiphenyl-4-yl)-2-methylbutyric acid (deoxoflobufen)

Arzneimittel-Forschung/Drug Research

Volumn 55, Issue 8, 2005, Pages 466-472

  Bulej, Petr ^a   Kuchař, Miroslav ^b   Panajotova, Vladimíra ^c   Jegorov, Alexandr ^a  

^a TEVA PHARMACEUTICALS   (Israel)

^b Zentiva Prague   (Czech Republic)

^c RE and D VÚFB sro   (Czech Republic)

Author keywords

Anti inflammatories; CAS 112344 52 2; CAS 847475 35 8; Deaxoflobufen, pharmacological profile; Flobufen; VUFB 16066; VUFB 19053

Indexed keywords

ANTIBODY; ANTIINFLAMMATORY AGENT; ANTIRHEUMATIC AGENT; CARRAGEENAN; DEOXOFLOBUFEN; FLOBUFEN; IMMUNOMODULATING AGENT; LEUKOTRIENE B4; OVALBUMIN; THIOGLYCOLIC ACID; UNCLASSIFIED DRUG;

ADJUVANT ARTHRITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; DRUG EFFICACY; DRUG TOXICITY; FEMALE; GRAFT VERSUS HOST REACTION; INFLAMMATION; MOUSE; MOUSE STRAIN; NONHUMAN; PERITONEUM EXUDATE; PERITONEUM MACROPHAGE; PHAGOCYTOSIS;

EID: 23944469866     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296890     Document Type: Article

References (15)

1. Flippen, J. L., Gilardi, R. D., (+)-2-(2-Fluoro-4-biphenyl)propionic acid (flurbiprofen). Acta Cryst. B31, 926 (1975)
2. Sunshine, A., Analgesic value of fenbufen in postoperative patients. A comparative oral analgesic study of fenbufen, aspirin, and placebo. J. Clin Pharmacol. 15, 591 (1975)
3. Kuchař, M., Maturová, E., Bru̇nová, B., et al., Quantitative relations between structure and antiinflamatory activity of aryloxoalkanoic acids. Coll. Czech. Chem. Commun. 53, 1862 (1988)
4. Panajotová, V., Anděrová, E., Jandera, A., et al., Pharmacological profile of the novel potent antirheumatic 4-(2',4'- difluorobiphenyl-4-yl)-2-methyl-4-oxobutanoic acid. Arzneim. Forsch./Drug Res. 47, 648 (1997)
5. Jegorov, A., Sedmera, P., Havlíček, et al., Spectroscopic and structural study of flobufen. J. Fluorine Chem. 73, 213 (1995)
6. Kuchař, M., Poppová, M., Zunová, H. et al., 4-(2',4'-Difluorobiphenyl-4-yl)-2-methyl-4-oxobutanoic acid and its derivatives. Coll. Czech. Chem. Commun. 59, 2705 (1994)
7. Kuchař, M., Poppová, M., Jandera, A., et al., Chiral forms of 4-(2',4'-difluorobiphenyl-4-yl)-2-methyl-4-oxobutanoic acid (Flobufen) and its metabolite. Synthesis and basic biological properties. Coll. Czech. Chem. Commun. 62, 498 (1997)
8. Jegorov, A., Hušák, M., Ondráček, J., et al., Structural study of flobufen. II. An unexpected role of packing effects on the dihedral angle of phenyl rings in crystal structures of 2,4-difluorobiphenyls. J. Fluorine Chem. 83, 111 (1997)
9. Bulej, P., Kuchař, M., Hušák, M. et al., Crystal structure of 4-(2',4'-difluorobiphenyl-4-yl)-2-methylbutanoic acid (deoxoflobufen), Z. Kristallogr. 219, 298 (2004)
10. Bulej P., Kuchař, M., Hušák M., et. al., Crystal structure of benzyl-ammonium 4-(2',4'-difluoro-biphenyl-4-yl)-2-methyl-butyrate, Z. Kristallogr. 219, 299 (2004)
11. Winter, C. A., Risley, E. A., Nuss, G. N., Carrageenan induced oedema in hind paw of the rat as an assay for antiinflammatory drugs. Proc. Soc. Exp. Biol. Med. 111, 544 (1962)
12. Di Rosa, M., Biological properties of carrageenan. J. Pharm. Pharmacol. 24, 89 (1972)
13. Pearson, C. M., Wood, F. D., Studies of polyarthritis and other lesions induced in rats by injection of Mycobacterial adjuvant. I. General clinical and pathologic characterization and some modifying factors. Arthritis Rheum. 2, 440 (1959)
14. Taurog, J. D., Argentieri, D. C., McReynolds, R. A., Adjuvant arthritis. Methods Enzymol. 162, 339 (1988)
15. Větvička, V., Fornusek, I., Kopeček J., et al., Phagocytosis in human leucocytes: a simple micromethod. Immunol. Lett. 5, 97 (1982)